· Unique, patented 3D printing process enables production of large-scale components
· First direct investment by BASF Venture Capital in a company in China
Ludwigshafen, Germany, and Shanghai, China – November 6, 2018 – BASF Venture Capital GmbH is investing in Prismlab, a leading provider of 3D printing processes and 3D printers, headquartered in Shanghai, China. Prismlab has developed a patented printing process that is characterized by a very high printing speed, high level of precision, large printing scale and lower printing costs. BASF’s venture investment will enable us Prismlab to further accelerate our product development and innovation while strengthening the market reach to the global market.
“This is our first direct investment in a Chinese company,” said Markus Solibieda, Managing Director of BASF Venture Capital GmbH. “The trailblazing technology from Prismlab allows large and stable components, such as medical braces and anatomical models, to be 3D printed for the first time. This investment supports BASF’s strategy of actively advancing our technologies and expanding our product offering in the 3D printing sector.”
“China is transforming from a manufacturing-driven to an innovation-driven economy. This investment in Prismlab reflects our commitment to further expanding our innovation capabilities in China, and BASF Venture Capital plays an important role in helping us identifying potential partners that lead us to success,” said Dr. Zheng Daqing, BASF’s Senior Vice President, Business and Market Development Greater China.
“The 3D printing technology must continue to evolve before it is set to change the world. At Prismlab, we aim to spearhead and accelerate that change by providing solutions through specialized customization. The investment allows us to stay laser-focused on our R&D capability, a key factor to achieve that goal,” said Mr. Hou Feng, Founder and Chairman of Prismlab.
Prismlab has developed a patented 3D printing process, “Pixel Resolution Enhanced Technology”, based on stereolithography (SLA). SLA allows comparatively large components to be produced using light-curing resins. Our technology increases the printing resolution without compromising printing speed. In order to increase the amount of energy brought into a pixel, we divide each pixel in the resin into several small sections, which can be cured individually by exposure to LCD light. This makes the energy input into each pixel significantly higher than similar processes that expose each pixel to light once. This allows comparatively large and stable components or numerous parts to be printed in the same production step. With the use of LCD light, our machine also reduces process costs. This advantage opens opportunities in the footwear and furniture industry.
Along with this patented process, we also market 3D printers and other related services. Our technology can be used in various key customer applications, including invisible braces, and anatomical models for medical, and education and training purposes.
SLA uses a laser for layer-by-layer curing of a photopolymer solution to shape the required workpiece. SLA and LCD based printing processes determinate the size, stability, and usability of the components to be produced as they are limited by the size of the light spot and the intensity of the light. Benefit from our unique innovation in SLA technology, Prismlab indeed achieves the inspirational breakthrough and gives the SLA printing another distinct definition and solution.
Prismlab is now becoming China's leading provider of 3D printing products and solutions. In 2013, we successfully developed Sub-Pixel Micro Scanning (SMS) light-cured 3D printing technology. Our company’s vision is to be the leading industrial service provider for 3D Printing. Based on our patent technologies, Prismlab received funding from the National Key R&D Program of China. We are also the leading company of Additive Manufacturing Process and Equipment of Nanostructure project. Further information at www.prismlab.com/.
About BASF Venture Capital
BASF Venture Capital GmbH (BVC) was founded in 2001 and has offices in Europe, the U.S., China and Israel. The aim of BVC is to generate new growth potential for BASF by investing in new companies and funds. The focus of investment is on chemical products and new materials, software and services as well as innovative and digital business models in the broader field of chemistry. Further information at www.basf-vc.com.
BASF creates chemistry for a sustainable future. It combines economic success with environmental protection and social responsibility. The more than 115,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world. Its portfolio is organized into four segments: Chemicals, Performance Products, Functional Materials & Solutions and Agricultural Solutions. BASF generated sales of more than €60 billion in 2017. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (BAS). Further information at www.basf.com.